← FDA Drug Approvals (Drugs@FDA)

POSIMIR

NDA · New Drug Application · Sponsor: INNOCOLL · Approved 2021-02-01

Drug application

FDA Application #

NDA204803

Application type

New Drug Application

Brand name

POSIMIR

Generic name

Bupivacaine

Active ingredients

BUPIVACAINE

Dosage form

SOLUTION

Route

INFILTRATION

Marketing status

Discontinued

Sponsor

INNOCOLL

First approval

2021-02-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown